RANITIDINE HYDROCHLORIDE by Aurobindo Pharma is clinical pharmacology ranitidine hydrochloride is a competitive, reversible inhibitor of the action of histamine at the histamine h 2 -receptors, including receptors on the gastric cells. First approved in 2018.
Drug data last refreshed 18h ago
CLINICAL PHARMACOLOGY Ranitidine hydrochloride is a competitive, reversible inhibitor of the action of histamine at the histamine H 2 -receptors, including receptors on the gastric cells. Ranitidine hydrochloride does not lower serum Ca++ in hypercalcemic states. Ranitidine hydrochloride is not an…
Worked on RANITIDINE HYDROCHLORIDE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Bioavailability Study of Ranitidine Hydrochloride (Maximum Strength ZANTAC 150®) Compared to Two Different 150 mg Ranitidine Hydrochloride Oral Disintegrating Tablet (ODT) in Fasting, Healthy Male Volunteers